204 related articles for article (PubMed ID: 26631061)
1. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.
Nguyen C; Lu M; Fan Z; Bi X; Kellman P; Zhao S; Li D
J Cardiovasc Magn Reson; 2015 Dec; 17():107. PubMed ID: 26631061
[TBL] [Abstract][Full Text] [Related]
2. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
[TBL] [Abstract][Full Text] [Related]
4. The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wu R; An DA; Shi RY; Chen BH; Wu CW; Jiang M; Xu JR; Wu LM; Pu J
Eur J Radiol; 2020 Nov; 132():109333. PubMed ID: 33068839
[TBL] [Abstract][Full Text] [Related]
5. In vivo contrast free chronic myocardial infarction characterization using diffusion-weighted cardiovascular magnetic resonance.
Nguyen C; Fan Z; Xie Y; Dawkins J; Tseliou E; Bi X; Sharif B; Dharmakumar R; Marbán E; Li D
J Cardiovasc Magn Reson; 2014 Sep; 16(1):68. PubMed ID: 25230598
[TBL] [Abstract][Full Text] [Related]
6. Noncontrast T1ρ dispersion imaging is sensitive to diffuse fibrosis: A cardiovascular magnetic resonance study at 3T in hypertrophic cardiomyopathy.
Wang K; Zhang W; Li S; Jin H; Jin Y; Wang L; Li R; Yang Y; Zheng J; Cheng J
Magn Reson Imaging; 2022 Sep; 91():1-8. PubMed ID: 35525524
[TBL] [Abstract][Full Text] [Related]
7. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
[TBL] [Abstract][Full Text] [Related]
8. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement.
Shi RY; An DA; Chen BH; Wu R; Du L; Jiang M; Xu JR; Wu LM
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2229-2238. PubMed ID: 32666169
[TBL] [Abstract][Full Text] [Related]
10. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
12. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
13. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
[TBL] [Abstract][Full Text] [Related]
14. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
[TBL] [Abstract][Full Text] [Related]
15. In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.
Brouwer WP; Baars EN; Germans T; de Boer K; Beek AM; van der Velden J; van Rossum AC; Hofman MB
J Cardiovasc Magn Reson; 2014 Apr; 16(1):28. PubMed ID: 24766828
[TBL] [Abstract][Full Text] [Related]
16. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Ho CY; Abbasi SA; Neilan TG; Shah RV; Chen Y; Heydari B; Cirino AL; Lakdawala NK; Orav EJ; González A; López B; Díez J; Jerosch-Herold M; Kwong RY
Circ Cardiovasc Imaging; 2013 May; 6(3):415-22. PubMed ID: 23549607
[TBL] [Abstract][Full Text] [Related]
17. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance.
Hwang SH; Choi EY; Park CH; Paek MY; Greiser A; Kim TH; Choi BW
Int J Cardiovasc Imaging; 2014 Dec; 30 Suppl 2():137-44. PubMed ID: 25022430
[TBL] [Abstract][Full Text] [Related]
19. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
Kellman P; Wilson JR; Xue H; Bandettini WP; Shanbhag SM; Druey KM; Ugander M; Arai AE
J Cardiovasc Magn Reson; 2012 Sep; 14(1):64. PubMed ID: 22967246
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
